Results Case report A 35-year-old female with GH-secreting pituitary tumors was treated with surgery and medical therapy using the first-generation SSA, octreotide, and the D2 agonist, cabergoline
Unexplained Bruising: If you are developing bruises on parts of your body where you have not injected the medication (like your shins, arms, or torso), this is not caused by the injection technique and could indicate a systemic issue with blood clotting
Thats not the case
Meier JK, Schnetz M, Beck S, et al
Adenylyl cyclase activation upregulates cAMP production, which exerts its effects on downstream targets via cascade signaling
Weekly dosing sits in the optimal zone for both efficacy and real-world usability